DK1465917T3 - Mellemprodukter for LHRH-antagonistsyntesen, fremgangsmåder til deres fremstilling samt fremgangsmåder til fremstilling af LHRH-antagonister - Google Patents

Mellemprodukter for LHRH-antagonistsyntesen, fremgangsmåder til deres fremstilling samt fremgangsmåder til fremstilling af LHRH-antagonister

Info

Publication number
DK1465917T3
DK1465917T3 DK02781699T DK02781699T DK1465917T3 DK 1465917 T3 DK1465917 T3 DK 1465917T3 DK 02781699 T DK02781699 T DK 02781699T DK 02781699 T DK02781699 T DK 02781699T DK 1465917 T3 DK1465917 T3 DK 1465917T3
Authority
DK
Denmark
Prior art keywords
preparation
methods
boc
lhrh
4clphe
Prior art date
Application number
DK02781699T
Other languages
Danish (da)
English (en)
Inventor
Jon H Rasmussen
Palle H Rasmussen
Wolfgang O Wachs
Stefan Hansen
Jens Fomsgaard
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Application granted granted Critical
Publication of DK1465917T3 publication Critical patent/DK1465917T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK02781699T 2001-12-29 2002-12-23 Mellemprodukter for LHRH-antagonistsyntesen, fremgangsmåder til deres fremstilling samt fremgangsmåder til fremstilling af LHRH-antagonister DK1465917T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104463A SE0104463D0 (sv) 2001-12-29 2001-12-29 Mellanprodukter för syntes af LHRH-antagonister, sätt att framställa dem och sätt för framställning av LHRH-antagonister
PCT/IB2002/005583 WO2003055902A1 (en) 2001-12-29 2002-12-23 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production

Publications (1)

Publication Number Publication Date
DK1465917T3 true DK1465917T3 (da) 2007-02-19

Family

ID=20286557

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02781699T DK1465917T3 (da) 2001-12-29 2002-12-23 Mellemprodukter for LHRH-antagonistsyntesen, fremgangsmåder til deres fremstilling samt fremgangsmåder til fremstilling af LHRH-antagonister
DK05025717T DK1630169T3 (da) 2001-12-29 2002-12-23 Mellemprodukter for LHRH-antagonist-synthesen, fremgangsmåde til deres fremstilling og fremgangsmåde til fremstilling af LHRH-antagonister

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK05025717T DK1630169T3 (da) 2001-12-29 2002-12-23 Mellemprodukter for LHRH-antagonist-synthesen, fremgangsmåde til deres fremstilling og fremgangsmåde til fremstilling af LHRH-antagonister

Country Status (22)

Country Link
US (2) US20050124788A1 (el)
EP (2) EP1465917B1 (el)
JP (1) JP4272529B2 (el)
KR (1) KR100844520B1 (el)
CN (1) CN1304417C (el)
AT (2) ATE342913T1 (el)
AU (1) AU2002348749B2 (el)
CA (1) CA2471723C (el)
CY (2) CY1107580T1 (el)
DE (2) DE60215544T2 (el)
DK (2) DK1465917T3 (el)
ES (2) ES2275012T3 (el)
HK (1) HK1075052A1 (el)
IL (2) IL162788A0 (el)
NO (1) NO330129B1 (el)
NZ (1) NZ534245A (el)
PT (2) PT1465917E (el)
RU (1) RU2307125C2 (el)
SE (1) SE0104463D0 (el)
SI (1) SI1630169T1 (el)
WO (1) WO2003055902A1 (el)
ZA (1) ZA200405136B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4407322B2 (ja) * 2004-03-09 2010-02-03 味の素株式会社 ペプチドの製造方法
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
JOP20090061B1 (ar) 2008-02-11 2021-08-17 Ferring Int Center Sa طريقة معالجة سرطان البروستاتا بمضادات الهرمونات التناسلية GnRH
EP2447276A1 (en) * 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
ES2617336T3 (es) * 2010-10-27 2017-06-16 Ferring B.V. Procedimiento para la fabricación de degarelix y sus productos intermedios
MY182320A (en) 2012-06-01 2021-01-19 Ferring Bv Downstream process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098777A (en) * 1977-03-14 1978-07-04 Merck & Co., Inc. Process for the preparation of pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn
US5225598A (en) * 1990-03-30 1993-07-06 Union Carbide Chemicals & Plastics Technology Corporation Selective production of linear pentaethylenehexamine and hydroxyethyldiethylenetriamine
JPH05508859A (ja) * 1990-07-24 1993-12-09 イーストマン コダック カンパニー ペプチド合成方法
US5710246A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process for intermediates for the synthesis of LHRH antagonists
JP3621707B2 (ja) * 1996-10-30 2005-02-16 ファイザー・インク ピリドン―縮合したアザ二環式―またはシチシン誘導体、その製法および嗜癖治療におけるその用途
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE19941248A1 (de) 1998-09-01 2000-03-02 Asta Medica Ag Peptide mit N-substituierten Glycingruppen sowie diese enthaltende Arzneimittel zur Behandlung hormonabhängiger Tumore

Also Published As

Publication number Publication date
JP4272529B2 (ja) 2009-06-03
ATE342913T1 (de) 2006-11-15
DE60215544T2 (de) 2007-08-30
EP1465917A1 (en) 2004-10-13
ES2275012T3 (es) 2007-06-01
IL162788A (en) 2010-12-30
CN1304417C (zh) 2007-03-14
CA2471723C (en) 2011-02-15
CA2471723A1 (en) 2003-07-10
CN1622954A (zh) 2005-06-01
ATE371666T1 (de) 2007-09-15
AU2002348749B2 (en) 2008-09-04
RU2004119964A (ru) 2006-01-10
KR100844520B1 (ko) 2008-07-08
EP1630169A2 (en) 2006-03-01
NZ534245A (en) 2007-05-31
ES2296050T3 (es) 2008-04-16
US8173770B2 (en) 2012-05-08
NO330129B1 (no) 2011-02-21
NO20043047L (no) 2004-08-30
AU2002348749A1 (en) 2003-07-15
PT1630169E (pt) 2007-12-06
SE0104463D0 (sv) 2001-12-29
IL162788A0 (en) 2005-11-20
WO2003055902A1 (en) 2003-07-10
HK1075052A1 (en) 2005-12-02
DE60222189T2 (de) 2008-06-19
US20050124788A1 (en) 2005-06-09
RU2307125C2 (ru) 2007-09-27
EP1630169B1 (en) 2007-08-29
JP2005516962A (ja) 2005-06-09
CY1107580T1 (el) 2013-03-13
PT1465917E (pt) 2007-01-31
DK1630169T3 (da) 2008-01-02
CY1107025T1 (el) 2012-09-26
SI1630169T1 (sl) 2008-04-30
DE60222189D1 (de) 2007-10-11
EP1630169A3 (en) 2006-03-15
ZA200405136B (en) 2005-07-27
KR20040090965A (ko) 2004-10-27
EP1465917B1 (en) 2006-10-18
US20080306242A1 (en) 2008-12-11
DE60215544D1 (de) 2006-11-30

Similar Documents

Publication Publication Date Title
EA200300428A1 (ru) Антагонисты метаботропных рецепторов глутамата
CY1113029T1 (el) Παραγωγα αζαδικυκλο [3.1.0] εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
CY1113657T1 (el) Νεα παραγωγα βενζοφαινονης ή αλατα αυτων
PL1781683T3 (pl) Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich
NO20031687L (no) Veksthormonsekretagoger
CR7080A (es) Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
MX2007007725A (es) Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina (amida, sulfonamida, carbamato y urea), como antagonistas de los receptores cb1 de los cannabinoides.
DK1606242T3 (da) Azidfri fremgangsmåde til fremstilling af 1,2-diaminoforbindelser
DE60302558D1 (de) 5-substituierte alkylaminopyrazol-derivative als pestizide
MY136824A (en) Substituted benzoxazinones and uses thereof
CY1107580T1 (el) Ενδιαμεσα για συνθεση ανταγωνιστων lhrh, διαδικασια για τη παραγωγη τους, και διαδικασια για παραγωγη ανταγωνιστων lhrh
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
BR0307156A (pt) Derivado de pirimidina bicìclica fundida, composto, antagonistas de receptores e agentes profiláticos e terapêuticos
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
MXPA04005988A (es) 3,4-dihidro-1h-isoquinolin-2-il-derivados.
NO20060603L (no) Fremgangsmate for fremstillingen av fenyltetrazolderivater
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
BRPI0417300A (pt) métodos para a preparação de compostos de tiazolpirimidina
DK1496059T3 (da) Kondenseret bicyklisk pyrimidinderivat
WO2004078109A3 (en) PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS
BR0315348A (pt) Processo para a preparação de um composto, e composto
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler